Advertisement

Topics

Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway

07:56 EDT 17 Apr 2018 | SCRIP

Australia gets the ball rolling on its new pathway for provisional approval of innovative prescription medicines. 

      

Related Stories

 

Original Article: Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly's Oncology Drug Is First Candidate For Australia's New Provisional Approval Pathway"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...